✦ LIBER ✦

5.23 Phase 2 Study of Navitoclax (ABT-263) Safety and Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Interim Results

✍ Scribed by John F. Seymour; Andrew W. Roberts; Dennis A. Carney; Martin J.S. Dyer; Thomas J. Kipps; Michael Hallek; R. Gregory Bociek; Jennifer R. Brown; William G. Wierda; Kanti Rai; Moacyr Ribeiro de Oliveira; Evelyn McKeegan; Brenda Chyla; Todd Busman; Andrew Krivoshik; Sari Enschede; Rod Humerickhouse

Book ID: 119218968
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 71 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.177

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Substantial Susceptibility of Chronic Ly

Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease

✍ Roberts, A. W.; Seymour, J. F.; Brown, J. R.; Wierda, W. G.; Kipps, T. J.; Khaw, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 550 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

5.18 Milatuzumab as a Single Agent in Re

5.18 Milatuzumab as a Single Agent in Refractory Chronic Lymphocytic Leukemia: Interim Results of a Phase 1–2 Study and Future Plans

✍ Michal Haran; Alain Berrebi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 71 KB

Safety and efficacy of bortezomib and me

Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up

✍ James R. Berenson; Hank H. Yang; Robert A. Vescio; Youram Nassir; Russell Mapes; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 164 KB

Results of a phase 2 study of valproic a

Results of a phase 2 study of valproic acid alone or in combination with all-transretinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

✍ Andrea Kuendgen; Sabine Knipp; Frank Fox; Corinna Strupp; Barbara Hildebrandt; C 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 97 KB